Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by horseshack on Feb 15, 2023 4:25pm

CNN

I see bladder cancer problems finally made it on the news. This morning CNN talked about Merck's shortage of their BCG drug and that Oncologist's are resorting to giving half dosages or none at all. No mention of are little Canadian gem, interesting hmmmmm, maybe soon I hope.
Comment by N0taP00p on Feb 15, 2023 4:32pm
https://www.cnn.com/2023/02/15/health/cancer-drug-shortage-bcg/index.html
Comment by Legit62 on Feb 15, 2023 4:35pm
The world is about to find out what TLT is made of soon enough, and once the news releases start to come about how great our treatment is. This rediculously low SP will be history. Its been a long journey but we are less than a month away from BTD and possibly AA IMO hang tight
Comment by jewel9m on Feb 15, 2023 8:37pm
TLT phase(II) data is to be presented at the AUA annual meeting April 28 - May1 The AUA was mentioned multiple times in the CNN article about the shortage of BCG This is very close to the exact time the FDA has (60 days) to respond to TLT BTD application. Might be a good time for all the shareholders to contact CNN acticle author Elizabeth Cohen about TLT. Also Marta Wosinska the former FDA ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250